Two new reports from the Center for Economic and Social Research (CESR) at the USC Dornsife College of Letters, Arts and Sciences find that major health systems are not currently ready for the introduction of new Alzheimer’s treatments. The research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.

The two reports combine desk research with expert insights to provide a comprehensive review of Alzheimer’s disease in five European (EU5) countries (France, Germany, Italy, Spain and the United Kingdom) and the U.S. – with a focus on what healthcare systems could do to prepare for the introduction of a novel disease modifying treatment. The research follows the stages of the patient journey to assess the system-wide obstacles to the introduction of a new treatment and how these challenges might be overcome.

The reports were funded by Roche and released in July 2020 at the Alzheimer’s Association International Conference (AAIC).